4//SEC Filing
Patel Sujal M 4
Accession 0001808805-21-000027
CIK 0001808805other
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 8:49 AM ET
Size
8.7 KB
Accession
0001808805-21-000027
Insider Transaction Report
Form 4
Patel Sujal M
DirectorCEO, President, and Secretary10% Owner
Transactions
- Purchase
Common Stock
2021-12-01$4.73/sh+88,022$416,397→ 9,864,388 total - Purchase
Common Stock
2021-11-30$4.72/sh+161,978$764,779→ 9,776,366 total
Holdings
- 5,280,476(indirect: By LLC)
Common Stock
- 1,814,035(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Represents the weighted average share price of an aggregate total of 161,978 shares purchased in the price range of $4.48 to $4.85 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F2]Represents the weighted average share price of an aggregate total of 88,022 shares purchased in the price range of $4.44 to $5.00 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F3]Shares held by PFV I, LLC. The reporting person is the manager of PFV I, LLC.
- [F4]Shares held by Sujal Patel 2020 Children's Trust, u/a/d December 3, 2020 (the "Patel Trust"). The reporting person and the reporting person's spouse are the trustees of the Patel Trust.
Documents
Issuer
Nautilus Biotechnology, Inc.
CIK 0001808805
Entity typeother
Related Parties
1- filerCIK 0001378830
Filing Metadata
- Form type
- 4
- Filed
- Dec 1, 7:00 PM ET
- Accepted
- Dec 2, 8:49 AM ET
- Size
- 8.7 KB